Integral Health Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-500,000
| Closed | -$1.29M | – | 100 |
|
|
2024
Q2 | $1.29M | Buy |
+500,000
| New | +$1.29M | 0.12% | 69 |
|
|
2024
Q1 | – | Sell |
-450,000
| Closed | -$3.96M | – | 94 |
|
|
2023
Q4 | $3.96M | Buy |
450,000
+350,000
| +350% | +$3.08M | 0.54% | 59 |
|
|
2023
Q3 | $1.15M | Sell |
100,000
-150,000
| -60% | -$1.72M | 0.16% | 62 |
|
|
2023
Q2 | $6.33M | Hold |
250,000
| – | – | 0.78% | 47 |
|
|
2023
Q1 | $8.05M | Buy |
250,000
+10,000
| +4% | +$322K | 1.62% | 27 |
|
|
2022
Q4 | $4.43M | Buy |
240,000
+90,000
| +60% | +$1.66M | 0.93% | 38 |
|
|
2022
Q3 | $4.05M | Buy |
+150,000
| New | +$4.05M | 0.79% | 45 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$1.39M | – | 86 |
|
|
2021
Q3 | $1.39M | Buy |
+50,000
| New | +$1.39M | 0.4% | 61 |
|